Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Accelerated Phase
20%
Acute Leukemia
60%
Adult Respiratory Distress Syndrome
20%
Advanced Disease
40%
Advanced Stage
100%
Allogeneic Bone Marrow Transplantation
100%
Bone Marrow Transplantation
40%
Central Nervous System Bleeding
20%
Chronic Lymphocytic Leukemia
40%
Chronic Myeloid Leukemia
20%
Complete Remission
40%
Curative Treatment
20%
Cyclophosphamide
100%
Cyclosporine
40%
Diffuse Alveolar Hemorrhage
20%
Disease-free Survival
60%
Etoposide
100%
Fractionated Total Body Irradiation
100%
GVHD Prophylaxis
20%
Hematological Malignancies
100%
High Risk
100%
High-grade non-Hodgkin Lymphoma
20%
Host Disease
20%
Intensified Regimen
20%
Matched Unrelated Donor
20%
Methotrexate
20%
Multiple Organ Failure
20%
Myeloablative Therapy
20%
Non-Hodgkin Lymphoma
20%
Post-transplant Relapse
20%
Prednisone
40%
Prospective Clinical Trial
20%
Relapse Rate
40%
Treatment Failure
20%
Veno-occlusive Disease of the Liver
20%
VP16
20%
Well Tolerated
20%
Medicine and Dentistry
Acute Leukemia
60%
Acute Respiratory Distress Syndrome
20%
Allogenic Bone Marrow Transplantation
100%
Bleeding
20%
Bone Marrow Transplantation
40%
Central Nervous System
20%
Chronic Leukemia
40%
Chronic Myelogenous Leukemia
20%
Clinical Trial
20%
Cyclophosphamide
100%
Cyclosporine
40%
Disease Free Survival
60%
Diseases
40%
Etoposide
100%
Graft Versus Host Reaction
20%
Hematologic Malignancy
100%
Median Follow Up
20%
Methotrexate
20%
Multiple Organ Dysfunction Syndrome
20%
Non-Hodgkin Lymphoma
20%
Patient with Non-Hodgkins Lymphoma
20%
Prednisone
40%
Pulmonary Hemorrhage
20%
Recurrence Risk
40%
Vein Occlusion
20%
Whole Body Radiation
100%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Leukemia
60%
Adult Respiratory Distress Syndrome
20%
Chronic Leukemia
40%
Chronic Myeloid Leukemia
20%
Ciclosporin
40%
Clinical Trial
20%
Cyclophosphamide
100%
Disease Free Survival
60%
Diseases
40%
Etoposide
100%
Graft Versus Host Reaction
20%
Hematologic Malignancy
100%
Lung Hemorrhage
20%
Methotrexate
20%
Multiple Organ Failure
20%
Nonhodgkin Lymphoma
40%
Prednisone
40%
Recurrence Risk
40%
Remission
40%
Vein Occlusion
20%
Immunology and Microbiology
Allogeneic Bone Marrow Transplantation
100%
Bone Marrow Transplantation
50%
Central Nervous System
25%
Ciclosporin
50%
Cyclophosphamide
100%
Disease Free Survival
75%
Graft-Versus-Host Disease
25%
Methotrexate
25%
Prednisone
50%